• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology.V2 血管加压素受体突变:基于个体分子生物学的未来个体化治疗。
Front Endocrinol (Lausanne). 2023 May 24;14:1173601. doi: 10.3389/fendo.2023.1173601. eCollection 2023.
2
[Nephrogenic syndrome of inappropriate antidiuresis].肾源性抗利尿激素分泌异常综合征
Pan Afr Med J. 2019 Apr 29;32:210. doi: 10.11604/pamj.2019.32.210.6006. eCollection 2019.
3
Gain-of-function mutations of the V2 vasopressin receptor in nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a cell-based assay to assess constitutive water reabsorption.血管加压素受体 2 功能获得性突变与抗利尿激素不适当分泌综合征(NSIAD):一种评估水持续重吸收的基于细胞的检测方法。
Pflugers Arch. 2019 Oct;471(10):1291-1304. doi: 10.1007/s00424-019-02307-x. Epub 2019 Sep 5.
4
Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction.肾源性抗利尿激素分泌不当综合征(NSIAD):激活突变导致内分泌功能障碍的范例。
Pediatr Endocrinol Rev. 2006 Dec;4 Suppl 1:66-70.
5
V2 vasopressin receptor mutations.V2 血管加压素受体突变。
Vitam Horm. 2020;113:79-99. doi: 10.1016/bs.vh.2019.08.012. Epub 2019 Sep 13.
6
Novel signalling pathways in nephrogenic syndrome of inappropriate antidiuresis: functional implication of site-specific AQP2 phosphorylation.特发性抗利尿激素分泌不当综合征中的新型信号通路:特定部位 AQP2 磷酸化的功能意义。
J Physiol. 2024 Jul;602(13):3169-3189. doi: 10.1113/JP284039. Epub 2023 Mar 14.
7
V2R mutations and nephrogenic diabetes insipidus.V2R 突变与肾性尿崩症。
Prog Mol Biol Transl Sci. 2009;89:15-29. doi: 10.1016/S1877-1173(09)89002-9. Epub 2009 Oct 7.
8
Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus.一种导致肾性尿崩症的新型血管加压素-2受体突变的鉴定、特征描述及挽救
Clin Endocrinol (Oxf). 2009 Sep;71(3):388-93. doi: 10.1111/j.1365-2265.2008.03513.x. Epub 2008 Dec 18.
9
Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments.血管加压素 2 型受体替换(R137H/C/L)导致的肾性尿崩症和抗利尿激素不适当分泌综合征的功能特征:对治疗的影响。
Mol Pharmacol. 2010 May;77(5):836-45. doi: 10.1124/mol.109.061804. Epub 2010 Feb 16.
10
Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V).鉴定三种血管升压素受体 2 变体:一种明显的多态性(V266A)和两种失活突变(R181C 和 M311V)。
PLoS One. 2013 Jun 6;8(6):e65885. doi: 10.1371/journal.pone.0065885. Print 2013.

引用本文的文献

1
Ciliary G-Protein Coupled Receptor Signaling in Polycystic Kidney Disease.多囊肾病中的纤毛G蛋白偶联受体信号传导
Int J Mol Sci. 2025 May 22;26(11):4971. doi: 10.3390/ijms26114971.
2
Association of Elevated Serum Aldosterone Concentrations in Pregnancy with Hypertension.孕期血清醛固酮浓度升高与高血压的关联
Biomedicines. 2023 Nov 1;11(11):2954. doi: 10.3390/biomedicines11112954.

本文引用的文献

1
Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Randomized Controlled Trial.托伐普坦治疗常染色体显性遗传多囊肾病患儿和青少年患者的随机对照试验
Clin J Am Soc Nephrol. 2023 Jan 1;18(1):36-46. doi: 10.2215/CJN.0000000000000022.
2
Genetic basis of nephrogenic diabetes insipidus.遗传性尿崩症的遗传学基础。
Mol Cell Endocrinol. 2023 Jan 15;560:111825. doi: 10.1016/j.mce.2022.111825. Epub 2022 Nov 30.
3
Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones.通过特异性拮抗剂和激动剂药物伴侣对导致V2加压素受体突变的肾性尿崩症进行功能挽救
Front Pharmacol. 2022 Jan 25;13:811836. doi: 10.3389/fphar.2022.811836. eCollection 2022.
4
Clinical and Functional Characterization of a Novel Mutation in Causing Nephrogenic Diabetes Insipidus in a Four-Generation Chinese Family.一个四代中国家系中导致肾性尿崩症的新突变的临床和功能特征分析
Front Pediatr. 2021 Dec 9;9:790194. doi: 10.3389/fped.2021.790194. eCollection 2021.
5
Nephrogenic Syndrome of Inappropriate Antidiuresis Mimicking Hyporeninemic Hypoaldosteronism: Case Report of Two Infants.模仿低肾素性低醛固酮血症的肾源性抗利尿激素分泌异常综合征:两例婴儿病例报告
J Clin Res Pediatr Endocrinol. 2023 May 29;15(2):214-219. doi: 10.4274/jcrpe.galenos.2021.2021.0191. Epub 2021 Oct 14.
6
Valine-279 Deletion-Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis.精氨酸加压素受体2上的缬氨酸279缺失突变导致G蛋白结合位点受阻:一例临床肾性尿崩症病例及其亚分子致病分析。
Biomedicines. 2021 Mar 15;9(3):301. doi: 10.3390/biomedicines9030301.
7
Treatment and long-term outcome in primary nephrogenic diabetes insipidus.原发性肾性尿崩症的治疗及长期预后
Nephrol Dial Transplant. 2020 Dec 26. doi: 10.1093/ndt/gfaa243.
8
Vasopressin receptor 2 mutations in the nephrogenic syndrome of inappropriate antidiuresis show different mechanisms of constitutive activation for G protein coupled receptors.血管加压素受体 2 突变在抗利尿激素分泌不当综合征中表现出不同的 G 蛋白偶联受体组成性激活机制。
Sci Rep. 2020 Jun 4;10(1):9111. doi: 10.1038/s41598-020-65996-w.
9
Germline-Derived Gain-of-Function Variants of Gs-Coding Gene Identified in Nephrogenic Syndrome of Inappropriate Antidiuresis.胚系来源的 Gs 编码基因突变导致抗利尿不适当分泌综合征。
J Am Soc Nephrol. 2019 May;30(5):877-889. doi: 10.1681/ASN.2018121268. Epub 2019 Apr 8.
10
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease.托伐普坦治疗常染色体显性遗传多囊肾病的长期疗效观察。
Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1153-1161. doi: 10.2215/CJN.01520218. Epub 2018 Jul 19.

V2 血管加压素受体突变:基于个体分子生物学的未来个体化治疗。

V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology.

机构信息

Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary.

Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.

出版信息

Front Endocrinol (Lausanne). 2023 May 24;14:1173601. doi: 10.3389/fendo.2023.1173601. eCollection 2023.

DOI:10.3389/fendo.2023.1173601
PMID:37293495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10244717/
Abstract

The diluting and concentrating function of the kidney plays a crucial role in regulating the water homeostasis of the body. This function is regulated by the antidiuretic hormone, arginine vasopressin through the type 2 vasopressin receptor (V2R), allowing the body to adapt to periods of water load or water restriction. Loss-of-function mutations of the V2R cause X-linked nephrogenic diabetes insipidus (XNDI), which is characterized by polyuria, polydipsia, and hyposthenuria. Gain-of-function mutations of the V2R lead to nephrogenic syndrome of inappropriate antidiuresis disease (NSIAD), which results in hyponatremia. Various mechanisms may be responsible for the impaired receptor functions, and this review provides an overview of recent findings about the potential therapeutic interventions in the light of the current experimental data.

摘要

肾脏的稀释和浓缩功能在调节身体的水稳态方面起着至关重要的作用。这种功能通过抗利尿激素,精氨酸加压素通过 2 型血管加压素受体(V2R)来调节,使身体能够适应水负荷或水限制期。V2R 的功能丧失性突变导致 X 连锁肾性尿崩症(XNDI),其特征是多尿、多饮和低尿。V2R 的获得性功能突变导致肾性尿崩症不合时宜的抗利尿激素综合征(NSIAD),导致低钠血症。各种机制可能导致受体功能受损,本综述根据当前的实验数据,就潜在的治疗干预措施提供了最新发现的概述。